Does CORT pay a dividend?

The cached stock data on this page does not show a positive dividend yield for CORT. Dividend status can change, so verify the latest company filings before relying on income assumptions.

What does CORT stock do?

Specialty pharmaceutical company focused on selective cortisol modulators for metabolic and oncological disorders. Corcept utilizes a high-margin (98% gross) specialty pharmacy distribution model.

What is CORT stock's price target?

This cached page does not contain a precise model fair value for CORT.

The TradeMates model verdict for CORT is HOLD with an investment score of 62/100. Treat this as a model signal to review, not a personal buy recommendation.

Is CORT a good dividend stock?

CORT is not presented as a dividend idea on this cached TradeMates page because no positive dividend yield is available in the cached data.

CORT (CORT) Stock Analysis

Q: Is CORT stock a good investment?

The cached TradeMates AI model rates CORT as HOLD with an investment score of 62/100. The model rates CORT as a HOLD. While the 2026 guidance hike and Lifyorli launch are transformative, the current 227.5x P/E is prohibitive for new entry. This is algorithmic model output, not personal investment advice.

Verdict: HOLD

Elite margins and Q2 guidance hike provide a growth floor, but extreme valuation and heavy insider selling signal a short-term ceiling.

Investment score: 62/100

The model rates CORT as a HOLD. While the 2026 guidance hike and Lifyorli launch are transformative, the current 227.5x P/E is prohibitive for new entry.

Peers

RPRX
ZTS
VTRS
ELAN
AXSM

Peer	P/E	P/B	P/S	EV/EBITDA	ROIC %	Net margin %
RPRX	23.95	3.70	10.40	19.87	—	0.34
ZTS	12.59	9.93	3.35	9.72	—	0.28
VTRS	-67.30	1.40	1.42	12.95	—	-0.02
ELAN	-53.19	2.03	2.70	21.97	—	-0.05
AXSM	-62.91	220.07	17.05	-69.42	—	-0.27

View the full interactive analysis